Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment.
O'Kane
D
D
Devereux
C E
CE
Walsh
M Y
MY
Hoey
S E H
SE
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab